UNIMED’s sales increased by 9% to 104.3 million dinars at the end of September compared to the same period last year.
This sales performance was achieved thanks to a 78% increase in sales to the hospital market and a 6% rise in sales to pharmacies.
Unit production (ampoules, vials, syringes, bags) amounted to 190.2 million units at September 30, 2024, a slight decrease of 1% compared to the same period of the previous year.
Capital expenditure (intangible and tangible) amounted to 2.3 million dinars, in line with the company’s expansion investment plan.
Long-term debt amounted to 24.3 million dinars. Short-term debt amounted to 25.3 million dinars, consisting of 8.2 million dinars of bank loans due within one year, 0.2 million dinars of leasing loans and 16.9 million dinars of working capital loans.